FIELD: biotechnology, virology, medicine.
SUBSTANCE: invention relates to attenuated virus derived from modified Ankara vaccina virus. Said virus are not able for reproduction by replication in human cell lines. Also disclosed are application of virus or recombinant variants thereof as drug or vaccine, as well as method for inducing of immune response in patients with defected immunity, in patients having immunity to vaccine virus, or in patient during antiviral therapy.
EFFECT: variant of Ankara vaccina virus effective in medicine and veterinary.
86 cl, 15 dwg, 1 tbl, 2 ex
Authors
Dates
2006-12-27—Published
2001-11-22—Filed